Literature DB >> 25724680

Meta-analysis of associations between functional prolactin -1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus.

Young Ho Lee1, Sang-Cheol Bae, Gwan Gyu Song.   

Abstract

The aim of this study was to determine whether the prolactin -1149 G/T polymorphism confers susceptibility to systemic lupus erythematous (SLE) and rheumatoid arthritis (RA). A meta-analysis was conducted for examining the associations between prolactin -1149 G/T polymorphism and susceptibility to SLE or RA using allele contrast, recessive and dominant models, and homozygote contrast. A total of 10 comparative studies, consisting of 4 SLE and 6 RA studies, involving 4252 patients and 4949 controls, were included in the meta-analysis. No association between the prolactin -1149 G allele and SLE was found when all study subjects were considered together (OR = 1.019, 95 % CI = 1.841-1.236, p = 0.845). Stratification by ethnicity also indicated no association between the prolactin G allele and SLE in either Caucasian or Latin American populations. In contrast, a significant association was observed between the prolactin G allele and RA in all subjects (OR = 1.123, 95 % CI = 1.052-1.198, p = 4.6 × 10(-5)). After stratification by ethnicity, the G allele was found to be significantly associated with RA in Caucasians (OR = 1.112, 95 % CI = 1.041-1.189, p = 0.002). Furthermore, the prolactin -1149 G/T polymorphism was found to be associated with RA in Caucasians under the dominant model and under homozygote contrast. This meta-analysis demonstrates that the prolactin -1149 G/T polymorphism is associated with susceptibility to RA, but not SLE, in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25724680     DOI: 10.1007/s10067-015-2904-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Genome scan meta-analysis of rheumatoid arthritis.

Authors:  S J Choi; Y H Rho; J D Ji; G G Song; Y H Lee
Journal:  Rheumatology (Oxford)       Date:  2005-11-08       Impact factor: 7.580

3.  Extrapituitary prolactin promoter polymorphism in Czech patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Markéta Fojtíková; Marie Cerná; Pavlína Cejková; Sárka Ruzicková; Ctibor Dostál
Journal:  Ann Rheum Dis       Date:  2007-05       Impact factor: 19.103

4.  Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility.

Authors:  Young Ho Lee; John B Harley; Swapan K Nath
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

Review 5.  Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects.

Authors:  N Ben-Jonathan; J L Mershon; D L Allen; R W Steinmetz
Journal:  Endocr Rev       Date:  1996-12       Impact factor: 19.871

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

7.  Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death.

Authors:  C Mohan; Y Yu; L Morel; P Yang; E K Wakeland
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

Review 8.  Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus.

Authors:  A Stevens; D W Ray; J Worthington; J R Davis
Journal:  Lupus       Date:  2001       Impact factor: 2.911

9.  Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin.

Authors:  C V Clevenger; D H Russell; P M Appasamy; M B Prystowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

10.  The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population.

Authors:  Zyanya Reyes-Castillo; Ana Laura Pereira-Suárez; Claudia Azucena Palafox-Sanchez; Héctor Rangel-Villalobos; Ciro Estrada-Chávez; Edith Oregón-Romero; Luis Ignacio Angel-Chávez; Salvador Muñoz-Barrios; Miriam Ruth Bueno-Topete; José Francisco Muñoz-Valle
Journal:  Gene       Date:  2013-05-07       Impact factor: 3.688

View more
  6 in total

1.  Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets.

Authors:  Yaoyang Liu; Zhiguo Zhang; Qianmei Jin; Yang Liu; Zijian Kang; Yongbao Huo; Zhengwen He; Xu Feng; Jian Yin; Xin Wu; Huaizhou Wang; Huji Xu
Journal:  Endocrine       Date:  2019-03-18       Impact factor: 3.633

2.  Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism.

Authors:  A E Shindler; E L Hill-Yardin; S Petrovski; N Bishop; A E Franks
Journal:  J Autism Dev Disord       Date:  2020-01

3.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Lectin, galactoside-binding, soluble, 3 rs4652 A/C gene variation and the risk for rheumatoid arthritis.

Authors:  Mahdi Atabaki; Mohammad Hashemi; Hamid Daneshvar; Ebrahim Alijani
Journal:  Biomed Rep       Date:  2017-01-09

5.  Prolactin rs1341239 T allele may have protective role against the brick tea type skeletal fluorosis.

Authors:  Bing-Yun Li; Yan-Mei Yang; Yang Liu; Jing Sun; Yan Ye; Xiao-Na Liu; Hong-Xu Liu; Zhen-Qi Sun; Mang Li; Jing Cui; Dian-Jun Sun; Yan-Hui Gao
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

Review 6.  Insight into the Endocrine System and the Immune System: A Review of the Inflammatory Role of Prolactin in Rheumatoid Arthritis and Psoriatic Arthritis.

Authors:  Man W Tang; Samuel Garcia; Danielle M Gerlag; Paul P Tak; Kris A Reedquist
Journal:  Front Immunol       Date:  2017-06-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.